Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 14, 2016
Analysis of CCN Protein Expression and Activities in Vasoproliferative Retinopathies
Sangmi Lee, Menna Elaskandrany, Afruja Ahad, et al.
RSC Medicinal Chemistry
|
January 29, 2024
Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers
Afruja Ahad, Fatima Aftab, Alexa Michel, et al.
Molecular and Cellular Biology
|
July 3, 2019
CCN1-Yes-Associated Protein Feedback Loop Regulates Physiological and Pathological Angiogenesis
Sangmi Lee, Afruja Ahad, Michele Luu, et al.
Bioconjugate Chemistry
|
February 23, 2018
Synthesis and Evaluation of a Novel <sup>64</sup>Cu- and <sup>67</sup>Ga-Labeled Neurokinin 1 Receptor Antagonist for in Vivo Targeting of NK1R-Positive Tumor Xenografts
Hanwen Zhang, Ananda Kumar Kanduluru, Pooja Desai, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 28, 2023
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models
Javier E López-Hernández, Nazia Nayeem, José P Cerón-Carrasco, et al.
ACS Pharmacology & Translational Science
|
January 17, 2024
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model"
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
September 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model"
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
December 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound
Nazia Nayeem, Sami Sauma, Afruja Ahad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M Carter, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
October 14, 2016
Analysis of CCN Protein Expression and Activities in Vasoproliferative Retinopathies
Sangmi Lee, Menna Elaskandrany, Afruja Ahad, et al.
RSC Medicinal Chemistry
|
January 29, 2024
Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers
Afruja Ahad, Fatima Aftab, Alexa Michel, et al.
Molecular and Cellular Biology
|
July 3, 2019
CCN1-Yes-Associated Protein Feedback Loop Regulates Physiological and Pathological Angiogenesis
Sangmi Lee, Afruja Ahad, Michele Luu, et al.
Bioconjugate Chemistry
|
February 23, 2018
Synthesis and Evaluation of a Novel <sup>64</sup>Cu- and <sup>67</sup>Ga-Labeled Neurokinin 1 Receptor Antagonist for in Vivo Targeting of NK1R-Positive Tumor Xenografts
Hanwen Zhang, Ananda Kumar Kanduluru, Pooja Desai, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 28, 2023
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models
Javier E López-Hernández, Nazia Nayeem, José P Cerón-Carrasco, et al.
ACS Pharmacology & Translational Science
|
January 17, 2024
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model"
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
September 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model"
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
December 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound
Nazia Nayeem, Sami Sauma, Afruja Ahad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M Carter, et al.
Page
of 2